Drug-induced TMA, such as dasatinib in this case, requires ADAMTS13 levels and direct antiglobulin tests to rule out TTP or autoimmune hemolysis.12,13,20 Complement testing, metabolic panels, and renal biopsy add clarity. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.